Buforin-2 (5-13)[17-20]2

General Information


DRACP ID  DRACP03493

Peptide Name   Buforin-2 (5-13)[17-20]2

Sequence  RAGLQFPVGRLLRRLLR

Sequence Length  17

UniProt ID  P55897 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03493

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H161N33O19

Absent amino acids  CDEHIKMNSTWY

Common amino acids  LR

Mass  230706

Pl  13.1

Basic residues  5

Acidic residues  0

Hydrophobic residues  8

Net charge  5

Boman Index  -4483

Hydrophobicity  -3.53

Aliphatic Index  137.65

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23776609

Title  A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5466

DRACP is developed by Dr.Zheng's team.